Related Experiment Videos

Aortobifemoral bypass--an enduring operation

F M Ameli1

  • 1Department of Surgery, Wellesley Hospital, Toronto, Ont.

Insights

Aortobifemoral bypass (ABF) is a successful surgical treatment for aortoiliac disease, offering excellent long-term results and symptom relief. This enduring procedure demonstrates low complication rates and predictable outcomes for patients.

Area of Science:

  • Vascular Surgery
  • Cardiovascular Medicine
  • Surgical Innovation

Background:

  • Aortobifemoral bypass (ABF) has been a treatment for aortoiliac occlusive or aneurysmal disease for four decades.
  • The procedure effectively alleviates symptoms such as claudication and critical limb ischemia.

Purpose of the Study:

  • To evaluate the long-term efficacy and outcomes of aortobifemoral bypass.
  • To highlight improvements in patient management and the predictability of results.

Main Methods:

  • Review of historical data and clinical outcomes associated with ABF.
  • Analysis of advancements in indications, preoperative assessment, and perioperative care.
  • Assessment of long-term patency rates, morbidity, and mortality.

Main Results:

  • ABF demonstrates excellent long-term patency rates.
  • The procedure is associated with low operative morbidity and mortality.
  • Outcomes are predictable, allowing for cost-benefit analysis.

Conclusions:

  • Aortobifemoral bypass remains a successful and enduring procedure for aortoiliac disease.
  • Significant improvements in care have enhanced patient outcomes.
  • The natural history and prognosis following ABF are well-understood.

Related Concept Videos